Double-blind substitution of vigabatrin and valproate in carbamazepine- resistant partial epilepsy

Epilepsy Research

Volumn 34, Issue 2-3, 1999, Pages 199-205

  Brodie, Martin J ^a   Mumford, John P ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Clinical trial; Epilepsy; Monotherapy; Sodium valproate; Vigabatrin

Indexed keywords

CARBAMAZEPINE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIPLOPIA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG TOLERABILITY; EPILEPSY; FATIGUE; FEMALE; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; VERTIGO; VOMITING; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; DOUBLE-BLIND METHOD; DRUG RESISTANCE; EPILEPSIES, PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETREATMENT; TREATMENT OUTCOME; VALPROIC ACID; VIGABATRIN;

EID: 0032891687     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00110-7     Document Type: Article

References (14)

1. Brodie M.J., Dichter M.A. Antiepileptic drugs. New Engl. J. Med. 334:1996;168-175.
2. Brodie M.J., Dichter M.A. Established antiepileptic drugs. Seizure. 6:1997;159-174.
3. Brodie, M.J., Yuen, A.W.C., and 105 Study group, 1997. Lamotrigine substitution study: evidence for synergism with sodium valproate? Epilepsy Res. 26, 423-432.
4. Brodie M.J. Antiepileptic drugs, clinical trials and the marketplace. Lancet. 347:1996;777-779.
5. Gram L. Experimental studies and controlled clinical testing of valproate and vigabatrin. Acta Neurol. Scand. 78:1998;241-270.
6. Leach J.P., Brodie M.J. Novel antiepileptic drugs: an explosion of activity. Seizure. 4:1995;5-17.
7. Marson A.G., Kadir Z.A., Hutton J.L., Chadwick D.W. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia. 30:1997;859-880.
8. Meldrum B.S. Update on the mechanism of action of antiepileptic drugs. Epilepsia. 37(Suppl. 6):1996;4-11.
9. Petroff O.A.C., Rothman D.L., Behar R.L., Mattson R.H. Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose. Neurology. 46:1996;1459-1463.
10. Richens A. Rational polypharmacy. Seizure. 5:1995;211-214.
11. Schachter S.C. Review of the mechanisms of action of antiepileptic drugs. CNS Drugs. 4:1995;469-477.
12. Schmidt D., Gram L. Monotherapy versus polytherapy in epilepsy. A reappraisal. CNS Drugs. 3:1995;194-208.
13. Sills G.J., Leach J.P., Butler E., Carswell A., Thompson G.G., Brodie M.J. Antiepileptic drug action in primary cultures of rat cortical astrocytes. Epilepsia. 37(suppl 6):1996;116-117.
14. Willmore, L.J., Shu, V., Wallin, B., and M88-194 Study group, 1996. Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. Neurology 46, 49-53.